Promoting therapeutic innovation: what do we do about drug-device combinations?

JAMA

2 March 2016 - There’s been a heated debate over the past year over whether legislative incentives are needed to encourage certain types of therapeutic innovation.

For more details, go to: http://jama.jamanetwork.com/article.aspx?articleID=2497893&utm_source=Silverchair_Information_Systems&utm_campaign=Tuesday_March_1_2016&utm_content=etoc&cmp=1&utm_medium=email

Michael Wonder

Posted by:

Michael Wonder